Niagen Bioscience, Inc. SEC filings NAGE
Niagen Bioscience, Inc. has 981 filings in SEC EDGAR's recent list, going back to Jan 18, 2007. Its latest annual report, Form ARS, was filed on Apr 29, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B5 | Prospectus supplement | Jul 10, 2026 | — |
| S-3 | Shelf registration | Jun 29, 2026 | — |
| S-8 | Employee stock plan registration | Aug 8, 2025 | — |
| S-8 | Employee stock plan registration | Aug 8, 2025 | — |
| 424B3 | Prospectus | Nov 21, 2024 | — |
| 424B5 | Prospectus supplement | Jul 6, 2023 | — |
| S-8 | Employee stock plan registration | Jun 22, 2023 | — |
| S-3 | Shelf registration | Jun 22, 2023 | — |
| 424B3 | Prospectus | Nov 17, 2022 | — |
| S-3 | Shelf registration | Nov 3, 2022 | — |
| 424B5 | Prospectus supplement | Oct 11, 2022 | — |
| 424B3 | Prospectus | Apr 22, 2021 | — |
| S-3 | Shelf registration | Mar 23, 2021 | — |
| S-8 | Employee stock plan registration | Aug 18, 2020 | — |
| 424B5 | Prospectus supplement | Jun 26, 2020 | — |
| S-3 | Shelf registration | Jun 12, 2020 | — |
| 424B3 | Prospectus | Jun 3, 2020 | — |
| S-3 | Shelf registration | May 21, 2020 | — |
| 424B3 | Prospectus | Oct 2, 2019 | — |
| S-3/A | Amendment no. 1 to s-3 | Sep 26, 2019 | — |
| S-3 | Shelf registration | Sep 12, 2019 | — |
| S-8 | Employee stock plan registration | Aug 22, 2018 | — |
| S-8 | Employee stock plan registration | Mar 23, 2018 | — |
| 424B3 | Prospectus | Jan 3, 2018 | — |
| S-3 | Shelf registration | Dec 14, 2017 | — |
| 424B3 | Prospectus | Nov 9, 2017 | — |
| S-8 | Employee stock plan registration | Oct 31, 2017 | — |
| S-8 | Employee stock plan registration | Oct 31, 2017 | — |
| S-3 | Shelf registration | Oct 31, 2017 | — |
| 424B3 | Prospectus | Jun 21, 2017 | — |
| S-3 | Shelf registration | Jun 9, 2017 | — |
| 424B5 | Prospectus supplement | Jun 3, 2016 | — |
| S-8 POS | Post-effective amendement no. 1 | May 27, 2016 | — |
| 424B5 | Prospectus supplement | Mar 11, 2016 | — |
| 424B5 | Prospectus supplement | Nov 5, 2015 | — |
| S-3/A | Form s-3/a | May 8, 2015 | — |
| S-3 | Shelf registration | Apr 2, 2015 | — |
| S-8 | Employee stock plan registration | May 30, 2014 | — |
| POS AM | Post effective amendment | Apr 30, 2012 | — |
| 424B5 | Prospectus supplement | Feb 1, 2012 | — |
| 424B5 | Prospectus supplement | Jan 27, 2012 | — |
| 424B3 | Prospectus | Nov 10, 2011 | — |
| S-3 | Shelf registration | Sep 1, 2011 | — |
| 424B3 | Prospectus | Aug 17, 2011 | — |
| 424B3 | Prospectus | Aug 11, 2011 | — |
| 424B3 | Prospectus | May 12, 2011 | — |
| S-1 | Registration statement | Mar 16, 2011 | — |
| 424B3 | Prospectus | Mar 16, 2011 | — |
| 424B3 | Prospectus | Nov 16, 2010 | — |
| S-1/A | Amended registration statement | Sep 15, 2010 | — |
| S-1 | Registration statement | Aug 18, 2010 | — |
| S-8 | Employee stock plan registration | Jul 8, 2010 | — |
| S-8 | Employee stock plan registration | Oct 17, 2008 | — |
| S-8 | Employee stock plan registration | Oct 17, 2008 | — |
Showing 54 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Medicinal Chemicals & Botanical Products (SIC 2833)
- Listed as
- NAGE (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Los Angeles, CA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1386570
- Former names
- ChromaDex Corp. (until Mar 10, 2025); CODY RESOURCES, INC. (until Jun 24, 2008)
Other Medicinal Chemicals & Botanical Products companies
- Definium Therapeutics, Inc. DFTX
- Regencell Bioscience Holdings Ltd RGC
- Curaleaf Holdings, Inc. CURLF
- Trulieve Cannabis Corp. TRLV
- Cronos Group Inc. CRON
- TFA Therapeutics, Inc. RAJAF
- Tilray Brands, Inc. TLRY
- SNDL Inc. SNDL
Source: SEC EDGAR filings. This is company-reported data, not investment advice.